Back to results
US 9,333,225 B2Granted
Oncolytic virotherapy for the therapy of ewing'S sarcoma
AssigneeDeutsches Krebsforschungzentrum
InventorsZoltan Kis, Jeaninne Lacroix, Barbara Leuchs, Monika Frank-Stohr, Jorg Schlehofer, Jean Rommelaere
Life of this patent
Estimating the term…
Abstract
The present invention relates to a parvovirus for the treatment of mesenchymal tumors, preferably malignant bone tumors such as localized and metastasized bone tumors, in particular osteosarcoma and Ewing's sarcoma. A preferred parvovirus includes a replication competent parvovirus H-1PV.
Claims3
A method for the treatment of a Ewing's sarcoma comprising administering a parvovirus H1 (H1PV) to the tumor.
Dependencies are inferred from the claim text.